Annual Retained Earnings
-$2.41 B
-$67.09 M-2.87%
December 31, 2024
Summary
- As of February 22, 2025, BPMC annual retained earnings is -$2.41 billion, with the most recent change of -$67.09 million (-2.87%) on December 31, 2024.
- During the last 3 years, BPMC annual retained earnings has fallen by -$1.13 billion (-88.72%).
- BPMC annual retained earnings is now -5641.83% below its all-time high of -$41.92 million, reached on December 31, 2013.
Performance
BPMC Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$2.41 B
-$49.95 M-2.12%
December 31, 2024
Summary
- As of February 22, 2025, BPMC quarterly retained earnings is -$2.41 billion, with the most recent change of -$49.95 million (-2.12%) on December 31, 2024.
- Over the past year, BPMC quarterly retained earnings has dropped by -$106.23 million (-4.62%).
- BPMC quarterly retained earnings is now -2828.05% below its all-time high of -$82.21 million, reached on December 31, 2014.
Performance
BPMC Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
BPMC Retained Earnings Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -2.9% | -4.6% |
3 y3 years | -88.7% | -4.6% |
5 y5 years | -154.7% | -4.6% |
BPMC Retained Earnings Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -88.7% | at low | -88.7% | at low |
5 y | 5-year | -281.3% | at low | -341.1% | at low |
alltime | all time | -5641.8% | at low | -2828.1% | at low |
Blueprint Medicines Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | -$2.41 B(+2.9%) | -$2.41 B(+2.1%) |
Sep 2024 | - | -$2.36 B(+2.4%) |
Jun 2024 | - | -$2.30 B(+2.2%) |
Mar 2024 | - | -$2.25 B(-3.8%) |
Dec 2023 | -$2.34 B(+27.7%) | -$2.34 B(+5.0%) |
Sep 2023 | - | -$2.23 B(+6.4%) |
Jun 2023 | - | -$2.10 B(+6.8%) |
Mar 2023 | - | -$1.96 B(+7.1%) |
Dec 2022 | -$1.83 B(+43.7%) | -$1.83 B(+9.5%) |
Sep 2022 | - | -$1.67 B(+8.6%) |
Jun 2022 | - | -$1.54 B(+11.6%) |
Mar 2022 | - | -$1.38 B(+8.3%) |
Dec 2021 | -$1.28 B(+102.0%) | -$1.28 B(+33.3%) |
Sep 2021 | - | -$956.75 M(+14.0%) |
Jun 2021 | - | -$839.51 M(+14.8%) |
Mar 2021 | - | -$731.07 M(+15.8%) |
Dec 2020 | -$631.36 M(-33.2%) | -$631.36 M(+15.7%) |
Sep 2020 | - | -$545.69 M(-53.7%) |
Jun 2020 | - | -$1.18 B(+11.7%) |
Mar 2020 | - | -$1.06 B(+11.7%) |
Dec 2019 | -$945.24 M | -$945.24 M(+7.5%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2019 | - | -$878.91 M(+12.0%) |
Jun 2019 | - | -$784.63 M(+14.6%) |
Mar 2019 | - | -$684.95 M(+14.6%) |
Dec 2018 | -$597.54 M(+68.0%) | -$597.54 M(+15.5%) |
Sep 2018 | - | -$517.22 M(+16.4%) |
Jun 2018 | - | -$444.50 M(+6.5%) |
Mar 2018 | - | -$417.45 M(+17.4%) |
Dec 2017 | -$355.59 M(+71.4%) | -$355.59 M(+16.0%) |
Sep 2017 | - | -$306.56 M(+14.0%) |
Jun 2017 | - | -$268.86 M(+14.2%) |
Mar 2017 | - | -$235.45 M(+13.5%) |
Dec 2016 | -$207.47 M(+53.7%) | -$207.47 M(+11.4%) |
Sep 2016 | - | -$186.21 M(+9.9%) |
Jun 2016 | - | -$169.37 M(+12.6%) |
Mar 2016 | - | -$150.48 M(+11.5%) |
Dec 2015 | -$134.97 M(+64.2%) | -$134.97 M(+13.0%) |
Sep 2015 | - | -$119.40 M(+11.8%) |
Jun 2015 | - | -$106.76 M(+13.8%) |
Mar 2015 | - | -$93.78 M(+14.1%) |
Dec 2014 | -$82.21 M(+96.1%) | -$82.21 M |
Dec 2013 | -$41.92 M | - |
FAQ
- What is Blueprint Medicines annual retained earnings?
- What is the all time high annual retained earnings for Blueprint Medicines?
- What is Blueprint Medicines annual retained earnings year-on-year change?
- What is Blueprint Medicines quarterly retained earnings?
- What is the all time high quarterly retained earnings for Blueprint Medicines?
- What is Blueprint Medicines quarterly retained earnings year-on-year change?
What is Blueprint Medicines annual retained earnings?
The current annual retained earnings of BPMC is -$2.41 B
What is the all time high annual retained earnings for Blueprint Medicines?
Blueprint Medicines all-time high annual retained earnings is -$41.92 M
What is Blueprint Medicines annual retained earnings year-on-year change?
Over the past year, BPMC annual retained earnings has changed by -$67.09 M (-2.87%)
What is Blueprint Medicines quarterly retained earnings?
The current quarterly retained earnings of BPMC is -$2.41 B
What is the all time high quarterly retained earnings for Blueprint Medicines?
Blueprint Medicines all-time high quarterly retained earnings is -$82.21 M
What is Blueprint Medicines quarterly retained earnings year-on-year change?
Over the past year, BPMC quarterly retained earnings has changed by -$106.23 M (-4.62%)